Literature DB >> 16116467

T cells and viral persistence: lessons from diverse infections.

Paul Klenerman1, Ann Hill.   

Abstract

Persistent virus infections create specific problems for their hosts. Although the dynamics of immune responses after acute infection are well studied and very consistent, especially in mouse models, the patterns of responses noted during persistent infection are more complex and differ depending on the infection. In particular, CD8(+) T cell responses differ widely in quantity and quality. In this review we examine these diverse responses and ask how they may arise; in particular, we discuss the function of antigen re-encounter and the CD4(+) T cell responses to and the escape strategies of specific viruses. We focus on studies of four main human pathogens, cytomegalovirus, Epstein-Barr virus, human immunodeficiency virus and hepatitis C virus, and their animal models.

Entities:  

Mesh:

Year:  2005        PMID: 16116467     DOI: 10.1038/ni1241

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  177 in total

1.  Programmed cell death-1 single-nucleotide polymorphism rs10204525 is associated with human immunodeficiency virus type 1 RNA viral load in HIV-1-infected Moroccan subjects.

Authors:  Hanâ Baba; Anass Kettani; Meryem Bouqdayr; Ahd Ouladlahsen; Rajaa Bensghir; Latifa Marih; Mustapha Sodqi; Soumaya Benjelloun; Sayeh Ezzikouri; Imane Zaidane; Fatima-Zahra Jadid; Kamal Marhoum El Filali; Lahcen Wakrim
Journal:  Med Microbiol Immunol       Date:  2021-05-24       Impact factor: 3.402

2.  Cutting edge: activation of virus-specific CD4 T cells throughout γ-herpesvirus latency.

Authors:  Michael L Freeman; Claire E Burkum; Kathleen G Lanzer; Meghan K Jensen; Mushtaq Ahmed; Eric J Yager; Emilio Flaño; Gary M Winslow; David L Woodland; Marcia A Blackman
Journal:  J Immunol       Date:  2011-11-11       Impact factor: 5.422

3.  Plasmacytoid dendritic cells control T-cell response to chronic viral infection.

Authors:  Luisa Cervantes-Barragan; Kanako L Lewis; Sonja Firner; Volker Thiel; Stephanie Hugues; Walter Reith; Burkhard Ludewig; Boris Reizis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

4.  Pharmacologic induction of CD8+ T cell memory: better living through chemistry.

Authors:  Luca Gattinoni; Christopher A Klebanoff; Nicholas P Restifo
Journal:  Sci Transl Med       Date:  2009-12-16       Impact factor: 17.956

Review 5.  Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns.

Authors:  Martin F Bachmann; Gary T Jennings
Journal:  Nat Rev Immunol       Date:  2010-10-15       Impact factor: 53.106

Review 6.  Translating insights from persistent LCMV infection into anti-HIV immunity.

Authors:  Elizabeth B Wilson; David G Brooks
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

7.  Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure.

Authors:  Alexandre Harari; Felicitas Bellutti Enders; Cristina Cellerai; Pierre-Alexandre Bart; Giuseppe Pantaleo
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

8.  [Viral infections].

Authors:  F Galán-Sánchez; C Fernández-Gutiérrez Del Álamo; M Rodríguez-Iglesias
Journal:  Medicine (Madr)       Date:  2014-03-19

9.  Viral targeting of fibroblastic reticular cells contributes to immunosuppression and persistence during chronic infection.

Authors:  Scott N Mueller; Mehrdad Matloubian; Daniel M Clemens; Arlene H Sharpe; Gordon J Freeman; Shivaprakash Gangappa; Christian P Larsen; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

10.  Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection.

Authors:  Silvana Gaudieri; Andri Rauch; Lawrence P Park; Elizabeth Freitas; Susan Herrmann; Gary Jeffrey; Wendy Cheng; Katja Pfafferott; Kiloshni Naidoo; Russell Chapman; Manuel Battegay; Rainer Weber; Amalio Telenti; Hansjakob Furrer; Ian James; Michaela Lucas; Simon A Mallal
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.